Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Interview with CEO on Upcoming Clinical Trial

View:

Post by SkywalkerofLuke on Mar 28, 2023 3:58pm

Interview with CEO on Upcoming Clinical Trial

A US survey found that 5% of people (approximately 12.2 million adults) reported experiencing chronic cough in the previous 12 months. The chronic cough market is expected to reach $11.38B by 2029.

I’ve been following AGN.c AGNPF (a clinical stage drug development company). This interview with their CEO gives updates on the previously announced 180 patient, 90-day Phase 2b clinical study of Ifenprodil for chronic cough that will begin in Q3.

There’s clearly a huge opportunity in finding a solution to chronic cough and AGN is poised to find the solution.

https://www.youtube.com/watch?v=zpvV0-fELgc

125

Comment

Comment by C10H12N2 on Mar 28, 2023 7:33pm

Man these bots post up some dumb down stuff. The video attached is from 2 months ago. Is it that hard to see they have NO MONEY to run a Chronic Cough trial or any trial? What money they'll raise will go to ineffective marketing and their personal bank accounts. There's nothing new to see here.

Comment

Algernon Pharmaceuticals Inc.